Login / Signup

Risk factors for red blood cell alloimmunization in patients with hematologic malignancy.

Pakthipa PattarakosolNattarat LorucharoenPhandee WatanaboonyongcharoenPonlapat Rojnuckarin
Published in: Transfusion medicine (Oxford, England) (2024)
The prevalence of RBC alloimmunization in the patients with hematologic malignancy was 4.8%. The alloimmunization rate of the AML subgroup was higher than those of other hematologic malignancies. The detection of autoantibodies and the AML diagnosis were identified as potential risk factors for RBC alloimmunization.
Keyphrases
  • red blood cell
  • sickle cell disease
  • acute myeloid leukemia
  • systemic lupus erythematosus
  • risk factors
  • allogeneic hematopoietic stem cell transplantation
  • loop mediated isothermal amplification
  • open label